Financials data is unavailable for this security.
View more
Year on year DiaSorin SpA 's revenues fell -15.64%from 1.36bn to 1.15bn. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a -33.65% reduction in net income from 240.91m to 159.85m.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in EURView more
In 2023, DiaSorin SpA increased its cash reserves by 15.94%, or 38.54m. The company earned 311.66m from its operations for a Cash Flow Margin of 27.14%. In addition the company used 29.10m on investing activities and also paid 235.96m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in EURView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in EUR
Year on year, growth in earnings per share excluding extraordinary items dropped -33.41%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 0.1329 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
